APGRX
Price
$27.00
Change
+$0.25 (+0.93%)
Updated
Jun 22 closing price
Net Assets
129.5M
RSLAX
Price
$71.21
Change
+$0.59 (+0.84%)
Updated
Jun 22 closing price
Net Assets
91.47B
Interact to see
Advertisement

APGRX vs RSLAX

APGRX vs RSLAX Comparison Chart in %
View a ticker or compare two or three
VS
APGRX vs. RSLAX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGRX is a Buy and RSLAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLAX has more cash in the bank: 91.5B vs. APGRX (129M). RSLAX pays higher dividends than APGRX: RSLAX (0.21) vs APGRX (0.00). APGRX was incepted earlier than RSLAX: APGRX (13 years) vs RSLAX (24 years). RSLAX (1.74) is less costly to investors than APGRX (1.28). RSLAX is a more actively managed with annual turnover of: 41.00 vs. APGRX (38.00). RSLAX has a lower initial minimum investment than APGRX: RSLAX (250) vs APGRX (1000000). APGRX annual gain was more profitable for investors over the last year : 36.06 vs. RSLAX (21.98). APGRX return over 5 years is better than : 24.07 vs. RSLAX (-6.60).
APGRXRSLAXAPGRX / RSLAX
Total Expense Ratio1.261.7472%
Annual Report Gross Expense Ratio1.281.7474%
Fund Existence13 years24 years-
Gain YTD21.42516.432130%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets129M91.5B0%
Annual Yield % from dividends0.000.21-
Returns for 1 year36.0621.98164%
Returns for 3 years63.8138.67165%
Returns for 5 years24.07-6.60-365%
Returns for 10 years86.5883.31104%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSGRX93.50N/A
N/A
Putnam Small Cap Growth R
PIIOX14.97N/A
N/A
Principal International Equity Index R3
EMRZX23.20N/A
N/A
VanEck Emerging Markets Z
TROIX17.90N/A
N/A
T. Rowe Price Overseas Stock I
ARTNX21.27-0.11
-0.51%
Artisan Select Equity Investor